Responses of neoplasms to local immunotherapy.
D000818:Animals; D000917:Antibody Formation; D000951:Antigens, Neoplasm; D001943:Breast Neoplasms / Q000188:drug therapy / Q000276:immunology; D002280:Basal Cell Carcinoma / Q000188:drug therapy / Q000276:immunology; D002294:Carcinoma, Squamous Cell / Q000276:immunology; D002722:Chlorobenzenes / Q000627:therapeutic use; D004357:Drug Synergism; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007111:Immunity, Cellular; D007167:Immunotherapy; D008214:Lymphocytes / Q000276:immunology; D009000:Monocytes / Q000276:immunology; D009182:Mycosis Fungoides / Q000188:drug therapy / Q000276:immunology; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D012878:Skin Neoplasms / Q000276:immunology; D013299:Streptodornase and Streptokinase / Q000627:therapeutic use; D014373:Tuberculin
D000951:Antigens, Neoplasm; D002722:Chlorobenzenes; D014373:Tuberculin; D013299:Streptodornase and Streptokinase